Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phase II trial of erlotinib plus capecitabine as first-line treatment for metastatic pancreatic cancer (XELTA study).
Anticancer Res. 2013 Feb;33(2):717-23.
Anticancer Res. 2013.
PMID: 23393373
Clinical Trial.
Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation Study.
Insua YV, Cámara J, Vázquez EB, Fernández A, Rivera FV, Silva MJVV, Barbazán J, Muinelo-Romay L, Folgar SC, Abalo A, López-López R, Abal M, Alonso-Alconada L.
Insua YV, et al. Among authors: folgar sc.
Int J Mol Sci. 2017 Jun 13;18(6):1265. doi: 10.3390/ijms18061265.
Int J Mol Sci. 2017.
PMID: 28608814
Free PMC article.
Item in Clipboard
Cite
Cite